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In adult primary visual cortex (V1), dendritic spines are more
persistent than during development. Brain-derived neurotrophic
factor (BDNF) increases synaptic strength, and its levels rise during
cortical development. We therefore asked whether postsynaptic
BDNF signaling through its receptor TrkB regulates spine persis-
tence in adult V1. This question has been difficult to address
because most methods used to alter TrkB signaling in vivo affect
cortical development or cannot distinguish between pre- and
postsynaptic mechanisms. We circumvented these problems by
employing transgenic mice expressing a dominant negative TrkB–
EGFP fusion protein in sparse pyramidal neurons of the adult
neocortex and hippocampus, producing a Golgi-staining-like pat-
tern. In adult V1, expression of dominant negative TrkB-EGFP
resulted in reduced mushroom spine maintenance and synaptic
efficacy, accompanied by an increase in long and thin spines and
filopodia. In contrast, mushroom spine maintenance was unaf-
fected in CA1, indicating that TrkB plays fundamentally different
roles in structural plasticity in these brain areas.
adult cortical plasticity  BDNF signaling  synapse stability 
transgenic mice
During development, synapse formation and elimination areregulated by molecular cues, spontaneous activity, and expe-
rience (1, 2). Most glutamatergic synapses on excitatory neurons are
situated on dendritic spines. Live imaging of neurons expressing
GFP has provided important information on the dynamics of spine
formation and maintenance (3–8). Filopodia are short-lived finger-
shaped protrusions and believed to be precursors of dendritic spines
(9, 10). Newly formed spines are often thin or long and appear and
disappear within days. Some mature into mushroom or stubby
spines, which are more stable and often persist for months (7, 8).
There are strong correlations between spine size, spine persistence,
synaptic efficacy, and the number of -amino-3-hydroxy-5-methyl-
4-isoxazolepropionate receptors (AMPARs) at the postsynaptic
density (8, 11, 12). With development and aging of the cortex, there
is a shift toward larger and more persistent spine types (3, 7, 13).
Spine dynamics are influenced by plasticity. Long-term potenti-
ation in hippocampus is associated with an increase in spine size
(14) and spine formation (15), whereas term depression is associ-
ated with spine elimination (16). Interestingly, reducing synaptic
input results in an increase in spine numbers, probably due to
homeostatic mechanisms (17–19).
Ocular dominance plasticity in V1 is associated with initial
pruning and later formation and stabilization of spines (20, 21) and
occurs predominantly during a critical period of development.
Maturation of the extracellular matrix is a major factor in ending the
critical period, probably by increasing spine and axon stability
(20–22)
BDNF signaling through TrkB receptors is a key player in visual
plasticity (23, 24). It drives the development of inhibitory innerva-
tion, an important factor in ocular dominance plasticity (25, 26).
BDNF is also implicated in directly effecting structural (27–29) and
functional changes (30–34) in excitatory neurons. Several studies
indicate that postsynaptic TrkB signaling stimulates the formation
and maturation of spines (35, 36). As BDNF expression rises in V1
upon eye opening and reaches maximal levels at early adulthood
(26, 37), increased TrkB-signaling may determine the increased
spine persistence observed in adult V1. However, a recent study
indicated that, whereas postsynaptic TrkB signaling is essential for
synapse formation in developing hippocampal neurons, it is dis-
pensable for spine maintenance in adult CA1 (38). Whether the
same holds true for adult V1 is currently unknown.
To resolve this issue, we set out to analyze the roles of postsyn-
aptic TrkB signaling in spine maintenance in adult V1 and CA1.
This problem has been difficult to address because the various
methods used for altering TrkB signaling in vivo also affect cortical
development or do not allow dissection of pre- and postsynaptic
mechanisms. We bypassed these problems by employing transgenic
mice expressing an EGFP fusion protein of the truncated TrkB
receptor (TrkB.T1–EGFP), which acts as a dominant negative
receptor (39) or a membrane-associated EGFP (EGFP-F) in sparse
pyramidal neurons in the adult neocortex and hippocampus starting
6 weeks after birth. This Golgi-staining-like expression pattern
permitted us to study structural modifications in pyramidal neurons
mediated by postsynaptic inhibition of TrkB signaling, without
disrupting development of the cortical circuitry or extracellular
matrix. We provide evidence that postsynaptic TrkB signaling is a
key determinant of spine maintenance in adult V1 but has much less
influence on spines in CA1.
Results
Expression of EGFP-F or TrkB.T1–EGFP in Individual Neurons of the
Adult Brain. To express EGFP-F or TrkB.T1–EGFP in comparable,
individual pyramidal neurons in the adult cortex and hippocampus,
three transgenic mouse lines were created. The first line, Cre-3487,
carried a Cre transgene under the control of the calciumcalmod-
ulin-dependent kinase II (CaMKII) promoter and defined the
Golgi-staining-like expression pattern. The other lines, TLG 498
and TLT 817, defined what protein was expressed in a Cre-
dependent fashion, i.e., EGFP-F or TrkB.T1–EGFP respectively. In
mice double transgenic for CaMKII-Cre and TrkB.T1–EGFP or
EGFP-F, EGFP fluorescence was detected in isolated pyramidal
neurons in layers IIIII and V of the neocortex and pyramidal and
granule cells of the hippocampus, starting around 6 weeks after
birth and accumulating during the following weeks (Fig. 1 A and B).
Conflict of interest statement: No conflicts declared.
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: AMPAR, -amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor;
EGFP-F, membrane-associated EGFP; CaMKII, calciumcalmodulin-dependent kinase II;
mEPSC, miniature excitatory postsynaptic current; LSL, lox-Stop-lox.
†Present address: Picower Center for Learning and Memory, Massachusetts Institute of
Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4307.
§To whom correspondence should be addressed. E-mail: c.levelt@ioi.knaw.nl.
© 2006 by The National Academy of Sciences of the USA








Comparable expression patterns were observed in mice double
transgenic for CaMKII-Cre and TrkB.T1–EGFP or EGFP-F
although recombination was less efficient in TrkB.T1–EGFP mice.
Representative sections of TrkB.T1–EGFP-expressing neurons in
V1 and CA1 are shown in Fig. 1 C and D. To ensure that the
observed mosaicism was mediated by Cre-3487 and was not inher-
ent to the EGFP-F or TrkB.T1–EGFP transgenes, we confirmed
that, when crossed to broad Cre-expressing lines, TLG 498 and TLT
817 showed transgene expression in most pyramidal neurons (data
not shown).
Both TrkB.T1–EGFP and EGFP-F were detected in all com-
partments of the cell, including the spines (Fig. 2 A–D) and axons.
Biocytin injections showed that all dendritic protrusions were
labeled with EGFP-F (Fig. 2 E–G) or TrkB.T1–EGFP (Fig. 2 H–J).
This observation excludes the possibility that spines of EGFP-F- or
TrkB.T1–EGFP-expressing neurons appeared different due to
variation in EGFP localization. Altogether, these transgenic mice
were well suited for studying the different spine types in adult V1
and CA1 neurons.
TrkB.T1–EGFP Expression Reduces Mushroom Spines and Increases
Long and Thin Spines and Filopodia in V1 but Not in CA1. To test
whether expression of TrkB.T1–EGFP had any effects on spine
morphology in adult V1, pyramidal neurons in layer IIIII of
8-week-old transgenic mice were analyzed by confocal microscopy.
At this age, the cells had expressed the transgene for up to 2 weeks.
Dendritic protrusions on basal and proximal and distal apical
dendrites were classified in different spine categories (mushroom,
long, thin, or stubby) or as filopodia and counted (see Fig. 7B).
Compared with EGFP-F-expressing neurons, mushroom and
stubby spines of TrkB.T1–EGFP neurons were reduced by 60% and
85%, respectively (P  0.0001; Fig. 3A). On the other hand, there
were 2–3 times more long and thin spines (P  0.0001) and 22 times
more filopodia (P  0.0001). The total density of protrusions was
reduced by 24% (P  0.0001). Protrusion changes in apical and
basal dendritic segments were similar (data not shown).
These results suggested that, from the onset of TrkB.T1–EGFP
expression, the density of mushroom and stubby spines declined,
whereas thin and long spines and filopodia increased. To verify this
finding, we assessed the densities of different spine types before the
onset of TrkB.T1–EGFP expression (6 weeks of age). Neurons in
V1 from 5-week-old WT mice were labeled with DiI by using
diolistics. At this age, the critical period is just closing and spine
morphologies are becoming similar to the adult situation. We
detected a slightly higher density of mushroom spines than in adult
EGFP-F-expressing neurons (7.8%, P  0.05, Fig. 3A). In addition,
we detected higher densities of long spines (2.4-fold, P  0.005) and
filopodia (20-fold, P  0.0001) but a 40% lower density of stubby
spines (P  0.005) than in adult EGFP-F-expressing neurons. In
most respects TrkB.T1–EGFP-expressing neurons in adult V1
resembled pyramidal neurons in 5-week-old V1 more than those in
adult V1. However, even compared with neurons in younger V1,
TrkB.T1–EGFP-expressing cells showed a 65% reduction of mush-
room and stubby spines (P  0.0001) and an increase in thin spines
(2.3-fold, P  0.0001) and filopodia (1.7-fold, P  0.0001). The fact
that the density of long spines on TrkB.T1–EGFP-expressing
neurons was similar to their density in pyramidal neurons in
5-week-old V1 may indicate that reduced TrkB signaling inhibits
Fig. 1. Expression of TrkB.T1–EGFP in adult visual cortex and hippocampus.
(A) TrkB.T1–EGFP expression in primary visual cortex (V1) is mosaic and re-
stricted to pyramidal neurons of layer IIIII and V. (B) In hippocampus, TrkB.T1–
EGFP expression occurs in pyramidal cells and granule cells. Inverted grayscale
images of Cy3-fluorescence are shown. A higher magnification of TrkB.T1–
EGFP pyramidal neurons in V1 (C) and CA1 (D) show expression in all cellular
compartments. [Scale bars: 100 m (A–B) and 50 m (C–D).]
Fig. 2. EGFP-F and TrkB.T1–EGFP label all dendritic protrusions. High mag-
nification projections of confocal images of dendritic protrusions from V1
neurons expressing EGFP-F (A) and TrkB.T1–EGFP (B) show that distinct pro-
trusions are labeled. Similar labeling was observed in EGFP-F-expressing (C)
and TrkB.T1–EGFP-expressing (D) neurons of CA1. Confocal sections of biocy-
tin-filled EGFP-F-expressing neurons stained for GFP (E) and Avidin-Cy3 (F)
show that all protrusions are labeled with both GFP and biocytin (G). Com-
parable images for TrkB.T1–EGFP are represented (H–J). (Scale bar: 5 m.)
Fig. 3. TrkB.T1–EGFP-expressing neurons in V1, but not in CA1, have less
mushroom and stubby spines and more filopodia. (A) V1 total protrusions.
TrkB.T1–EGFP-expressing pyramidal cells in V1 show a 60–85% reduction in
mushroom and stubby spines, a 2- to 3-fold increase in thin and long spines,
and a 22-fold increase in filopodia. In comparison with 5-week-old WT neu-
rons labeled with DiI, TrkB.T1–EGFP-expressing neurons have 65% fewer
mushroom and stubby spines and more thin spines (2.3) and filopodia
(1.7). (B) CA1 total protrusions. In CA1 pyramidal cells, stubby spines are
reduced by 35%. No significant differences were found in other protrusions.
Error bars represent SEM. ***, (P  0.0001); **, (P  0.005); *, (P  0.05). n 
3,417 spines for V1; 989 spines for CA1; and 328 spines for 5-week-old V1.
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their maturation into larger and shorter mushroom spines, but only
dynamic studies can confirm this.
In CA1 pyramidal cells expressing TrkB.T1–EGFP or EGFP-F,
no significant differences were seen in the densities of long (P 
0.558), thin (P  0.57), or mushroom (P  0.065) spines or filopodia
(P  0.6) (Fig. 3B). There was a moderate decrease of 35% in
stubby spines (P  0.01) in TrkB.T1–EGFP neurons. Together,
these results show that postsynaptic TrkB signaling is an important
regulator of adult spine morphology in adult V1 but much less so
in CA1.
Reduced Mushroom Spine Maintenance of TrkB.T1–EGFP-Expressing
Pyramidal Cells in V1 but Not in CA1. Over 70% of all spines in adult
V1 are persistent for periods of months (7, 8). Our observation that
60% of mushroom spines disappear within 2 weeks of TrkB.T1–
EGFP expression therefore suggests that spine maintenance is
affected rather than the development of new mushroom spines.
Because large mushroom spines are the most persistent (13), it is
expected that spine loss due to natural turnover affects this popu-
lation the least. However, the spine head diameterlength corre-
lation plot (Fig. 4A) shows that mushroom spine heads of TrkB.T1–
EGFP-expressing neurons are smaller than those of EGFP-F-
expressing cells, with an almost complete loss of mushroom spines
with head diameters 0.8 m. Mushroom spines of TrkB.T1–
EGFP-expressing neurons average a mean diameter of 0.49 m
compared with 0.78 m of EGFP-F-expressing neurons (P 
0.0001, Fig. 4B). TrkB.T1–EGFP-expressing spines are also 30%
longer than EGFP-F-expressing mushroom spines (P  0.0001),
with an average length of 1.5 m. In CA1, mushroom spines of
TrkB.T1–EGFP-expressing cells have an average head diameter of
0.7 m and are similar to those of EGFP-F-expressing cells (P 
0.69, Fig. 4D). However, spine length increased by 32%, resulting
in a mean length of 1.32 m (P  0.0001). This difference was
mainly caused by increased spine length within the population of
spines with heads 0.8 m (38% increase, P  0.0001 compared
with 14% increase in larger spines, P  0.068). Spine length
distribution within this population was shifted upward, and spines
longer than 1.5 m increased from 2.5% in EGFP-F neurons to
35% in TrkB.T1–EGFP neurons (P  0.0001, KS-Z value  2.1)
(Fig. 4C). Together, these data indicate that postsynaptic TrkB
signaling in adult V1 pyramidal neurons is essential for the main-
tenance of mushroom spines although this finding does not seem to
be true for CA1 neurons.
Decreased Miniature Excitatory Postsynaptic Current (mEPSC) Fre-
quency and Amplitude in TrkB.T1–EGFP-Expressing Pyramidal Cells.
Under normal circumstances, there is a good correlation between
spine head size and synaptic efficacy. To test whether TrkB.T1–
EGFP-induced reductions in mushroom spine density and head size
had a functional correlate, we measured mEPSCs in neurons
expressing EGFP-F (n  4) and TrkB.T1–EGFP (n  4). Ampli-
tude and frequency of mEPSCs were markedly different in EGFP-F
and TrkB.T1–EGFP-expressing neurons (Fig. 5). The average
Fig. 4. TrkB.T1–EGFP expression influences spine length and head size in V1.
(A) Correlation plot of spine head diameter and spine length shows that, in V1,
TrkB.T1–EGFP expression results in the loss of the largest mushroom spines and
a shift toward longer spines with smaller heads. (B) The mean head diameter
of mushroom spines on TrkB.T1–EGFP-expressing neurons in V1 is reduced by
40% whereas their length is increased by 30%. (C) In CA1, TrkB.T1–EGFP
expression does not affect spine head size but does result in increased num-
bers of spine length among spines with small heads. (D) In CA1, mushroom
spines of TrkB.T1–EGFP-expressing neurons do not show a difference in the
mean spine head diameter but are 32% longer. Error bars represent SEM. ***,
P  0.0001.
Fig. 5. Reduced mEPSC amplitude and frequency in V1 neurons of TrkB.T1–
EGFP. (A) Two sets of typical recordings from EGFP-F and TrkB.T1–EGFP-
expressing neurons. (B) Distribution of mEPSC amplitudes in two typical
recordings in EGFP-F-expressing (Upper Left) and TrkB.T1–EGFP-expressing
(Upper Right) neurons and their corresponding mEPSC frequencies (Lower).
(C) Cumulative probability distribution of inter-event (mEPSC) interval in
EGFP-F and TrkB.T1–EGFP-expressing neurons. The frequency in TrkB.T1–
EGFP-expressing neurons was significantly reduced (P  0.0001, KS-Z  11.28).
Median interval was 0.19  0.09 s in EGFP-F and 0.62  0.11 s in TrkB.T1–EGFP-
expressing neurons. (D) Cumulative probability distribution of mEPSC ampli-
tude in EGFP-F and TrkB.T1–EGFP-expressing neurons. The amplitude was
significantly reduced in TrkB.T1–EGFP-positive neurons (P  0.0001, KS-Z 
7.44). Median amplitude was 10.95  0.07 pA and 8.9  0.3 pA in EGFP-F and
TrkB.T1–EGFP positive neurons, respectively. Error bars represent SEM.








distribution of time intervals between events was shifted toward
larger intervals in TrkB.T1–EGFP-expressing neurons (Fig. 5C,
P  0.0001, KS-Z value  11.28), resulting in a median interval of
0.62  0.11 s and 0.19  0.09 s in TrkB.T1–EGFP and EGFP-F-
expressing cells, respectively. The average distribution of ampli-
tudes was shifted toward smaller amplitudes in the TrkB.T1–EGFP-
expressing cells (Fig. 5D, P  0.0001, KS-Z  7.44), resulting in a
strong decrease in the number of events with amplitudes 25 pA.
Median amplitudes of mEPSCs in TrkB.T1–EGFP and EGFP-F-
expressing cells were 8.9  0.03 pA and 10.95  0.07 pA,
respectively.
To exclude the possibility that the reduction of mEPSCs in
TrkB.T1–EGFP-expressing cells was due to an acute effect of
reduced TrkB signaling, mEPSCs were measured in slices of WT
C57BL6 mice in the absence or presence of a cell-permeable
inhibitor of Trk phosphorylation, K252a (n  7). The Friedman test
showed that application of K252a in WT mice had no significant
effect on either frequency (P  0.565) or amplitude (P  0.779)
(data not shown).
Discussion
We examined the role of postsynaptic TrkB signaling in spine
maintenance by expressing a dominant negative TrkB.T1–EGFP
fusion protein in sparse pyramidal neurons of the adult neocortex
and hippocampus of transgenic mice. This approach had several
advantages over previously used models for studying the function of
TrkB in cortical pyramidal cells. First, it permitted us to study
morphological changes caused by interfering with TrkB-signaling in
individual pyramidal neurons within an unaffected environment.
Second, because synaptic partners of transgene-expressing neurons
were genetically unaffected, pre- and postsynaptic influences of
interfering with TrkB signaling could be discerned. Third, because
expression of TrkB.T1–EGFP was confined to the adult brain (6
wks), neuronal developmental was unaffected.
We found that, after 2 weeks of TrkB.T1–EGFP expression,
spine morphology of pyramidal neurons in V1 had become remi-
niscent of neurons in the much younger visual cortex. Compared
with EGFP-F-expressing neurons in adult V1, mushroom and
stubby spines were reduced by 60–85% whereas the numbers of
filopodia and long and thin spines had increased strongly. Even
compared with pyramidal neurons in V1 of younger mice (5 wks),
filopodia and thin spine types were more abundant and mature
spine types were more reduced in TrkB.T1–EGFP-expressing neu-
rons. These structural changes were accompanied by a reduction in
both the amplitude and frequency of mEPSCs. The amplitude of
mEPSCs is mainly a reflection of the number of AMPARs at the
postsynaptic density, which in turn correlates with spine head size
(12). Large mushroom spines show strong AMPA currents,
whereas thinner spines may carry ‘‘silent synapses’’ containing
N-methyl-D-asparate receptors but little or no AMPAR (11). In
TrkB.T1–EGFP-expressing neurons, mEPSCs with large ampli-
tudes disappeared almost entirely, and mEPSCs were smaller on the
whole. This finding agreed well with the observed changes in
mushroom head sizes (Fig. 4). The frequency of mEPSCs is
influenced by the number of AMPAR-containing synapses and the
efficiency of presynaptic vesicle release. In TrkB.T1–EGFP-
expressing cells, the decrease in mEPSC frequency was twice that
of the total spine density change but correlated with the reduction
in mushroom and stubby spines. This result could imply that
TrkB.T1–EGFP-expressing neurons had more silent synapses,
which would fit the observed increase in immature-appearing spine
types. However, we cannot rule out that presynaptic vesicle release
was indirectly affected by postsynaptic changes caused by TrkB.T1–
EGFP expression.
Previous experiments have shown that, during barrel cortex
development, BDNF signaling through postsynaptic TrkB recep-
tors is essential for the insertion of AMPARs at the postsynaptic
density (40) and the development of mature synapses. As new
spines also form and mature in adult V1, it is possible that this
process is affected by postsynaptic expression of TrkB.T1–EGFP.
What would the morphological consequences be of such a defect?
Studies employing in vivo two-photon imaging have shown that, in
adult V1, 70% of all spines are persistent (3, 7). Large mushroom
spines are the most stable population (13). If the transition of long
or thin spines into mushroom spines were to be inhibited for a
2-week time period in adult mice, we would expect to see a small
reduction in the number of mushroom spines caused by natural
turnover, with the population of large mushroom spines being least
affected. In contrast, we found a strong decrease in the number of
mushroom spines, with the largest mushroom spines disappearing
altogether in TrkB.T1–EGFP-expressing neurons (Fig. 4A). Taken
together, these findings indicate that reduced postsynaptic TrkB
signaling results in reduced maintenance of large spines and a
concomitant reduction in synaptic efficacy.
Recently, it was shown that TrkB deficiency in pyramidal neurons
of adult CA1 had little effect on their total protrusion density (38).
Because this finding contrasted with our observations in V1, we also
analyzed spine morphologies of TrkB.T1–EGFP-expressing neu-
rons in CA1. In agreement with the previous study, we observed no
significant differences in spine densities of EGFP-F or TrkB.T1–
EGFP-expressing pyramidal cells in CA1. Also, most spine subtypes
were unaffected except for a 35% decrease in stubby spines (Fig.
3B). Head diameters of mushroom spines did not change, suggest-
ing that postsynaptic TrkB is not involved in their maintenance. We
did observe that small mushroom spines were longer, which may be
an indication of reduced transition of long spines into mushroom
spines due to TrkB.T1–EGFP expression (Fig. 4 C and D), but only
dynamic imaging can confirm this. The different roles postsynaptic
TrkB plays in the maintenance of spines in V1 and CA1 may well
explain why long term TrkB deficiency results in the retraction of
neurites and possibly degeneration of neurons in neocortex but not
in hippocampus (41).
We observed that TrkB.T1–EGFP-expressing neurons in V1 had
more long and thin spines and filopodia. The most intuitive
explanation is that homeostatic mechanisms induced the formation
of novel spines in an attempt to keep total synaptic input constant.
A reduction in Ca2 signaling due to the loss of synaptic input could
lie at the basis of such a homeostatic response (19). In addition,
some filopodia and thin and long spines may be retracting mush-
room spines (8). Last, an increase in filopodia formation by
truncated TrkB expression has also been observed in cultured
hippocampal neurons. This effect was independent of BDNF, but
involved p75 neurotrophin receptor (p75NTR) (42). We cannot
exclude that the same process takes place in adult V1, in which case
spine loss and the filopodia formation in TrkB.T1–EGFP-
expressing neurons would be unrelated events. However, the low
levels of p75NTR expression in cortical pyramidal cells and the lack
of filopodia formation in the TrkB.T1–EGFP-expressing hip-
pocampal neurons in which spine loss is much less prominent make
this explanation less likely.
The results presented here define postsynaptic TrkB signals as an
important determinant of synapse maintenance in V1. Therefore,
the rise of BDNF levels in the developing visual cortex is likely to
result in enhanced rigidity of its connections. The fact that
TrkB.T1–EGFP-expressing neurons showed extensive changes in
spine morphology in adult V1 indicates that the mature extracel-
lular matrix does not inhibit structural plasticity altogether but
supports the view that the extracellular matrix and TrkB signaling
have synergistic roles in synaptic stability and maintenance (43).
Our observations also imply that, in V1, BDNF is capable of
bidirectionally regulating synapse strength, with increased TrkB
signaling resulting in synapse strengthening and decreased signaling
resulting in synapse weakening. In this respect, it is remarkable that
BDNF expression is reduced by stimuli associated with dendritic
pruning, such as monocular deprivation (44), and that its release is
reduced by stimuli inducing long-term depression (LTD) (45). Our
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finding that signals through TrkB are directly or indirectly involved
at maintaining AMPARs at the postsynaptic density may explain
the observation that BDNF interferes with the induction of LTD in
the visual cortex (33) and that monocular deprivation results in
reduced surface expression of AMPARs (46).
It is striking that the same mechanism is not functional at the
Schaffer collateral synapse where mushroom spine maintenance
is not affected by postsynaptic TrkB.T1–EGFP expression. A
possible mechanistic explanation for this difference is that
AMPARs are expressed at much higher levels in hippocampus
than in neocortex (47). This property may make hippocampal
neurons less sensitive to TrkB-mediated differences in AMPAR
expression (48) or trafficking (49) and, consequently, less prone
to undergo structural changes. This difference seems compatible
with the functions of synaptic plasticity in these areas. In V1,
plasticity is mostly aimed at setting up and maintaining an
efficient circuitry for the processing of visual input, which may
be achieved effectively through structural changes that are less
rapid and more permanent. Faster and less permanent forms of
plasticity seem more appropriate for the temporary storage and
transfer of information as occurs in hippocampus.
To comprehend the underlying biological mechanisms, it is
imperative to determine whether TrkB signaling regulates syn-
aptic stability at individual synapses or at the cellular level. It is
also important to identify the site of BDNF release and to
discern its autocrine and paracrine roles. Inactivation of the bdnf
gene in isolated neurons and analyzing their spine and bouton
morphology seems to be an appropriate approach for answering
these questions.
Materials and Methods
DNA Constructs and Production of Transgenic Mice. Constructs for
Cre-dependent expression of TrkB.T1–EGFP or EGFP-F were
created as follows. The lox-Stop-lox (LSL) cassette from PBS302
(GIBCOBRL, Bethesda, MD) was cloned into a Thy-1 pro-
moter containing expression vector, rendering pThy-LSL. cDNA
encoding amino acids 1–477 of TrkB and encompassing a 75-nt
fragment of the 5 untranslated region was cloned into the
polylinker of EGFP-N3 (BD Biosciences). The fragment en-
coding TrkB.T1–EGFP was cloned into pThy-LSL rendering
pThyLSL-TrkB.T1–EGFP. pThyLSL-EGFP-F was created by
cloning the fragment encoding EGFP fused to the Ha-ras
farnesylation site from pEGFP-F (BD Biosciences) into
pThy-LSL. For production of transgenic mice expressing Cre
under the control of the CaMKII promoter, pJTCre (50) was
used (Fig. 6, which is published as supporting information on the
PNAS web site).
Transgenic mice were created by pronuclear injections of
linearized DNA into fertilized C57BL6 oocytes. One of the
seven ThyLSL-TrkB.T1–EGFP founders (TLT-817) showed suf-
ficiently high EGFP levels for spine analysis. Nine ThyLSL-
EGFP-F founders were obtained, of which three showed suffi-
cient EGFP expression. Line TLG-498 was used in this study.
Sparse labeling of pyramidal neurons in adult cortex was
achieved by generating novel CaMKII-Cre transgenic mice.
Four CaMKII-Cre founders were produced, of which two
showed Cre recombination in a Golgi-staining-like pattern. Line
Cre-3487 is described here. All experiments involving mice were
approved by the institutional animal care and use committee of
the Royal Netherlands Academy of Arts and Sciences.
Histology and Immunohistochemistry. Eight-week-old mice double
transgenic for CaMKII-Cre and TrkB.T1–EGFP or EGFP-F
were anaesthetized with 0.1 mlg bodyweight Nembutal (Jans-
sen) and perfused with 4% paraformaldehyde (PFA) in PBS and
postfixed for 2 h. Coronal sections of 50 m were made by using
a vibratome (Leica VT1000S, Leica, Rijswijk, The Netherlands).
To allow long-term storage and reduce bleaching, free-floating
sections were stained by using mouse anti-GFP antibodies
(1:500, Chemicon), followed by Alexa Fluor 568-conjugated goat
anti-mouse antibodies (1:500, Invitrogen). Biocytin-injected
slices (300 m) were postfixed in 4% PFA and stained with
chicken anti-GFP antibodies (1:1000, Chemicon), followed by
Alexa Fluro 488-conjugated anti-chicken antibodies (1:500, In-
vitrogen) and Cy3-conjugated streptavidin (1:500, Vector Lab-
oratories) for the detection of biocytin.
Diolistics. Diolistics were essentially performed as described (51).
Briefly, 0.15 mg of DiI (Invitrogen) was mixed with 50 l of
methylene chloride and vortexed until completely dissolved. The
dissolved dye was added to 12 mg of 1.1-m tungsten particles
(Bio-Rad) on a glass slide. This mixture was spread across the
slide, and the solvent was allowed to evaporate for 2 min. The
coated particles were transferred to a 1.5-ml tube, resuspended
in 1 ml of distilled water, and sonicated. The suspension was
sucked into Tefzel tubing (Bio-Rad) with a syringe, and the
particles were allowed to settle for 2 min. The water was then
withdrawn, and the tube was dried with a flow of nitrogen gas
and cut into 13 mm pieces.
Fifty-micrometer coronal sections were shot by using the
Helios Gene Gun (Bio-Rad) at 80 psi through a membrane filter
with a 3-m pore size and 8  105 porescm2 (Corning). Sections
were left for at least 12 h to ensure good filling of the labeled
neurons.
Confocal Microscopy. EGFP-expressing, or DiI- or biocytin-
labeled neurons from layer IIIII of V1 or from CA1 were
imaged by using a Carl Zeiss CLSM 510 Meta confocal micro-
scope (Zeiss) with Argon (488 nm) and HeNe (543 nm) lasers.
The first branch points of basal, proximal apical, and distal apical
dendrites (Fig. 7A, which is published as supporting information
on the PNAS web site) were imaged at a scaling of 60 nm (63
objective and an optical zoom of 2.5) with 200-nm steps in the
z-plane. The back-projected pinhole was 190 nm. For each image
acquisition, the laser intensity and detector gain were adjusted
so that the entire detector range was used for the spines. The
image stacks were subjected to 3D reconstruction by using Zeiss
CLSM 510 Meta. At these settings, spine morphology was not
different from those that were subjected to blind deconvolution
(Huygens Essential, Hilversum, The Netherlands).
Spine Classification and Image Analysis. Dendritic protrusions were
classified as spines (mushroom, long, stubby, or thin) or filopodia
and quantified as the number of protrusions per 15-m segment
(details in Fig. 7B). Spine analysis was performed on V1 neurons
expressing EGFP-F (five mice, 19 neurons, 80 segments, and
1,447 spines) and TrkB.T1–EGFP (five mice, 25 neurons, 141
segments, and 1,970 spines) and on DiI-labeled neurons (2 mice,
10 neurons, 20 distal apical segments, 328 spines). For CA1
neurons, protrusions from basal and distal apical dendrites of
neurons expressing EGFP-F (three mice, 11 neurons, 22 seg-
ments, and 454 spines) and TrkB.T1–EGFP (four mice, 8
neurons, 29 segments, and 535 spines) were quantified likewise.
Size determination of mushroom spines was carried out by
using Zeiss CLSM IMAGE BROWSER 5 overlay tools. The longest
straight line in the spine head was counted as the head diameter.
The length of the entire spine (including head and stalk) was
measured by using a bent-line tool. Spine sizelength correlation
plots were performed on mushroom spines from distal apical
dendrites of neurons expressing EGFP-F (V1, 116 spines; CA1,
107) and TrkB.T1–EGFP (V1, 195 spines; CA1, 47). Statistical
significance of differences in spine numbers per segment, spine
length, or head size was determined by standard student’s t test.
Significance of differences in spine length distributions of CA1
mushroom spines was determined by the Kolmogorov-Smirnov
(KS) test.








Electrophysiology. Coronal slices (300 m) of V1 were prepared
from 8- to 10-week-old mice. Animals were killed by decapita-
tion, and brains were chilled in ice-cold carbogenated (95%
O25% CO2) sucrose-based artificial cerebrospinal f luid
(ACSF), containing 3.5 mM KCl, 2.4 mM CaCl2, 1.3 mM
MgSO4, 1.2 mM KH2PO4, 10 mM glucose, 26 mM NaHCO3, and
212.5 mM sucrose. Slices were stored in carbogenated normal
ACSF comprising 126 mM NaCl, 3 mM KCl, 2 mM MgSO4, 2
mM CaCl2, 10 mM Glucose, 1.20 mM NaH2PO4 and 26 mM
NaHCO3 (305 mM mOsm and pH 7.3).
Slices were transferred to a submerged recording chamber
with constant perfusion of carbogenated artificial cerebrospinal
f luid. EGFP-expressing neurons in layer IIIII of V1 were
patched under an Axioskop FS upright microscope equipped
with infrared differential interference contrast optics (Zeiss).
Borosilicate glass patch-pipettes (4–6 M) were filled with
K-gluconate internal solution containing 154 mM K-gluconate,
1 mM KCl, 0.5 mM EGTA, 10 mM Hepes, 4 mM Mg-ATP, 4 mM
K2phosphocreatine, 0.4 mM GTP (pH 7.3 and 0.290 mosm), and
3 mgml biocytin (Invitrogen) for intracellular labeling. In
whole-cell configuration, mEPSCs were recorded at 18–21°C by
using a patch-clamp amplifier (EPC8, HEKA Electronics, Lam-
brecht, Germany) in the presence of 1 M tetrodotoxin
(Alomone Labs, Jerusalem) while holding the membrane po-
tential at 	70 mV.
K252a (Calbiochem, San Diego, CA) was applied to slices at
200 nM. After stabilization, mEPSCs were recorded for 9 min as
baseline, 9 min in the presence of K252a, and 9 min after washing
it out. Signals were low-pass filtered at 3.0 KHz and digitized
at 10 KHz, with an ITC-16 computer interface (Instrutech,
Mineola, NY). Care was taken that series resistance remained
20 M.
Data Analysis. Mini Analysis (Synaptosoft Inc., Decatur, GA) was
used for analyzing mEPSCs. The amplitude threshold was set at
7 pA, which was 3 root-mean-square (RMS) noise in all
recordings. After automatic detection of mEPSCs by the soft-
ware, each mEPSC was visually inspected. Recordings with a
systematic drift in average mEPSC rise time of 10% were
excluded. mEPSCs with rise times 3 ms were omitted. Fre-
quencies and amplitude distributions of mEPSCs in EGFP-F
versus TrkB.T1–EGFP neurons were compared for statistical
significance by using the Kolmogorov-Smirnov test. Statistical
analysis of the effect of K252a was done by using the Friedman
test.
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